SPY vs XLV: SPDR S&P 500 ETF Trust vs Health Care Select Sector SPDR Fund Historical Returns & Investment Comparison

This SPY vs XLV comparison analyzes the historical stock performance of SPDR S&P 500 ETF Trust and Health Care Select Sector SPDR Fund side-by-side. Using real, adjusted market data, this tool shows how identical investments in both stocks would have performed over time—highlighting differences in returns, volatility, and consistency across market cycles.

Use the interactive calculator below to adjust the investment amount and time period, visualizing how SPDR S&P 500 ETF Trust and Health Care Select Sector SPDR Fund have historically performed against each other.

Compare Stock Performance

Select two stocks and an investment amount to see how they compare over time.

Compare any two stocks to see which performed better historically

Performance Summary

$10,000 invested from 1993 to 2025 (33 years)

Head-to-Head Record

16
SPY Wins
0
Ties
12
XLV Wins

Over the 28-year comparison period, SPDR S&P 500 ETF Trust outperformed Health Care Select Sector SPDR Fund in 16 years, while Health Care Select Sector SPDR Fund outperformed SPDR S&P 500 ETF Trust in 12 years.

SPY - SPDR S&P 500 ETF Trust

Average Annual Return:+11.71%
Best Year:+37.39% (1995)
Worst Year:-36.24% (2008)
Win Rate:81.8% (27/33 years)
Total Value:$250,597.02
Total Gain:+$240,597.02 (+2405.97%)

XLV - Health Care Select Sector SPDR Fund

Average Annual Return:+8.77%
Best Year:+38.66% (2013)
Worst Year:-22.50% (2008)
Win Rate:82.1% (23/28 years)
Total Value:$88,276.77
Total Gain:+$78,276.77 (+782.77%)

Overall Winner: SPY with an average annual return of 11.71% (vs 8.77% for XLV)

Understanding SPY vs XLV Performance

When comparing SPDR S&P 500 ETF Trust and Health Care Select Sector SPDR Fund, investors should consider multiple factors beyond just total returns. Volatility, consistency of growth, dividend payments, and sector-specific risks all play crucial roles in determining which stock might be better suited for your investment strategy and risk tolerance.

Historical performance data shows how each stock responded to market downturns, economic expansions, and company-specific events. While past performance doesn't guarantee future results, understanding these patterns can help inform investment decisions and portfolio allocation strategies.

Cumulative Growth Comparison

A $10,000 investment in SPDR S&P 500 ETF Trust grew to $250,597, compared to $88,277 for Health Care Select Sector SPDR Fund over the same period.

Year-by-Year Comparison

YearSPY ReturnSPY CumulativeXLV ReturnXLV CumulativeDifferenceWinner
1993 (Start)-$10,000.00-$10,000.00-Initial Investment
1994+8.71%$10,870.91---Tie
1995+0.67%$10,943.47---Tie
1996+37.39%$15,035.16---Tie
1997+21.20%$18,223.19---Tie
1998+33.14%$24,261.81---Tie
1999+28.03%$31,063.11+3.87%$10,387.02+24.16% (SPY)SPY
2000+20.66%$37,482.18+19.79%$12,442.96+0.87% (SPY)SPY
2001-8.85%$34,165.23-10.04%$11,193.62+1.19% (SPY)SPY
2002-10.13%$30,703.75+3.38%$11,572.30-13.51% (XLV)XLV
2003-22.42%$23,820.14-1.58%$11,389.59-20.84% (XLV)XLV
2004+24.18%$29,580.86+11.90%$12,744.46+12.29% (SPY)SPY
2005+10.75%$32,760.13+1.04%$12,876.80+9.71% (SPY)SPY
2006+5.32%$34,504.59+7.66%$13,863.70-2.34% (XLV)XLV
2007+13.84%$39,281.03+5.75%$14,661.04+8.09% (SPY)SPY
2008+5.33%$41,375.53+7.13%$15,706.02-1.80% (XLV)XLV
2009-36.24%$26,382.38-22.50%$12,172.49-13.74% (XLV)XLV
2010+22.65%$32,359.23+17.14%$14,258.40+5.52% (SPY)SPY
2011+13.14%$36,610.39+1.53%$14,477.21+11.60% (SPY)SPY
2012+0.85%$36,922.44+11.37%$16,123.49-10.52% (XLV)XLV
2013+14.17%$42,154.69+15.87%$18,682.08-1.70% (XLV)XLV
2014+29.00%$54,380.19+38.66%$25,905.04-9.66% (XLV)XLV
2015+14.56%$62,298.86+25.84%$32,598.91-11.28% (XLV)XLV
2016+1.29%$63,101.60+6.44%$34,698.94-5.15% (XLV)XLV
2017+13.59%$71,674.43-0.97%$34,360.79+14.56% (SPY)SPY
2018+20.78%$86,569.38+20.20%$41,302.90+0.58% (SPY)SPY
2019-5.25%$82,026.91+5.10%$43,408.44-10.34% (XLV)XLV
2020+31.09%$107,527.02+22.30%$53,090.16+8.78% (SPY)SPY
2021+17.24%$126,059.55+13.00%$59,989.60+4.24% (SPY)SPY
2022+30.51%$164,514.60+26.59%$75,938.07+3.92% (SPY)SPY
2023-18.65%$133,838.54-1.06%$75,132.36-17.59% (XLV)XLV
2024+26.71%$169,585.78+2.36%$76,905.82+24.35% (SPY)SPY
2025+25.59%$212,981.61+0.70%$77,445.92+24.89% (SPY)SPY
2026+17.66%$250,597.02+13.99%$88,276.77+3.68% (SPY)SPY

Annual returns include dividends and stock splits. Cumulative values show growth of $10,000 invested from the first year. Positive difference means SPY outperformed XLV that year.

Company Profiles

1

SPDR S&P 500 ETF Trust

SPY

SPY is the first exchange-traded fund (ETF) listed in the US. It is designed to track the S&P 500 Index, which measures the performance of the large-cap segment of the US equity market.

Key Innovations

  • First US-listed ETF

Business Segments

  • ETF
    Passive investment vehicle tracking the S&P 500.
2

Health Care Select Sector SPDR Fund

XLV

XLV seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index.

Business Segments

  • ETF
    US Health Care Sector Equities

How This Comparison Works

Our stock comparison tool uses adjusted closing prices to calculate year-by-year returns for both stocks. This ensures an apples-to-apples comparison that accounts for:

  • Dividends: All dividend payments are reinvested
  • Stock splits: Historical prices are adjusted for all splits
  • Head-to-head record: Shows which stock outperformed each year
  • Statistical analysis: Average returns, best/worst years, and win rates

Share This Comparison

Important Disclaimer

This comparison tool is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Past performance is not indicative of future results. Historical returns include dividends and stock splits but do not account for taxes, fees, inflation, or individual circumstances. Stock market investments carry risk, including the potential loss of principal. Always consult with a qualified financial advisor before making investment decisions. The data presented is based on historical market data and may contain inaccuracies or delays.